2Honkanen VE,McCirndle BW,Laxer RM,et al.Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease.Pediatr Cardiol,2003,24 (2):122~126.
4Kuramochi Y,Ohkubo T,Takechi N,et al.Feasibility of percutaneous transluminal coronary angioplasty to patients with Kawasaki Disease as an early management strategy.Pediatr Cardiol,2001,22 (3):183~187.
二级参考文献19
1邹凤彩 王军.早期川崎病误诊为脑炎三例报告[J].临床误诊误治,1995,8:95-96.
2[2]Suzuki A, Miyagawa-Tomita S. Nakazawa M, et al. Remodeling of coronary artery lesions due to Kawasaki disease: Comparison of arteriographic and immunohistochemical findings. Jpn Heart J, 2000, 41: 245- 256.
3[3]Rowley A, Shulman S. Kawasaki disease. In: Behrman RE, Kliegman RM, Arvin AM, eds. Nelson textbook of pediatrics. Philadeiphia: Saunders, 2000: 725 - 727.
4[9]0nouchi Z, Kawasaki T.Overview of pharmacological treatment of Kawasaki disease. Drugs, 1999, 58: 813-822.
5[1]Sumiya M,Super M,Tabona P, et al. Molecular basis of opsonic defect in immunodeficient children. Lancet,1991,337:1568
6[2]Madsen HO, Garred P, Kurtzhals JAL, et al. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics,1994,40:37
7[3]Lau YL, Lau CS, Chan SY, et al. Mannose-binding protein in Chinese patients with systemic lupus erythematosus.Arthritis Rheum,1996,39:706
8[4]Garred P,Thiel S,Madsen HO,et al. Gene frequency and partial protein characterization of an allelic variant of mannan binding protein associated with low serum concentration.Clin Exp Immunol,1992,90:517
9[5]Kurata H,Sannoh T,Kozntsumi Y, et al. Structure and function of mannan-binding proteins isolated from human liver and serum. J Biochem,1994,115:1148
10[6]Matsushita M. The lectin pathway of the complement system. Microbiol Immunol, 1996,40:887